Integra LifeSciences receives FDA clearance for Titanium Bone Wedges Integra LifeSciences announced the introduction of the Integra Titanium Bone Wedges, designed for internal fixation for bone fractures or osteotomies in the foot and ankle. The system has received 510(k) clearance from the U.S. Food and Drug Administration and will be featured at the American College of Foot and Ankle Surgeons 72nd Annual Scientific Conference. The Integra Titanium Bone Wedges may be used in corrective procedures, such as Cotton osteotomies of the medial cuneiform and Evans lengthening osteotomies. The Integra Titanium Bone Wedge is available in 15 different pre-shaped anatomical sizes, to accommodate various skeletal deformities in the foot.
UBS to hold a conference Global Healthcare Conference is being held in New York on May 18-20 with webcasted company presentations to begin on May 18 at 8 am; not all company presentations may be webcasted. Webcast Link